Brookfield Renewable Partners LP
BEP.UN
TELUS Corp
T
BCE Inc
BCE
4
Enbridge Inc
ENB
5
TC Energy Corp
TRP
CA Stock MarketDetailed Quotes
IPA ImmunoPrecise Antibodies Ltd
- 0.000
- 0.0000.00%
15min DelayMarket Closed Mar 10 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio24.94MShares0.00052wk Low-1.06EPS TTM0Float Cap0.000Historical High0.00P/E (Static)24.94MShs Float0.000Historical Low-0.85EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About ImmunoPrecise Antibodies Ltd Company
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.
Company Profile
SymbolIPA
Company NameImmunoPrecise Antibodies Ltd
Founded1983
MarketTSX
Employees85
Fiscal Year Ends04-30
Address3204 - 4464 Markham Street
CityVictoria
CountryCAN
Zip CodeV8Z 7X8
Phone+1 250 483-0308
Company Executives
- Name
- Position
- Salary
- Jennifer Bath
- Chief Executive Officer, President and Director
- --
- Dr. Ilse Roodink
- Chief Scientific Officer
- --
- Lisa Helbling
- Chief Financial Officer
- --
- Dr. James S. Kuo, M.D.
- Chairman of the Board
- --
- Dr. Anna Pettersson
- Director
- --
- Brian Lundstrom
- Director
- --
- Robert D. Burke
- Independent Director
- --
- Gregory S. Smith
- Independent Director
- --
Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.
Unlock Now